Solitron Devices (SODI) 10-Q 14 Jan 25 2025 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Nov. 30, 2024	Jan. 01, 2025
Document Information [Line Items]
Entity Central Index Key	0000091668
Entity Registrant Name	SOLITRON DEVICES INC
Amendment Flag	false
Current Fiscal Year End Date	--02-28
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2025
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Nov. 30, 2024
Document Transition Report	false
Entity File Number	001-04978
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	22-1684144
Entity Address, Address Line One	901 Sansburys Way
Entity Address, City or Town	West Palm Beach
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33411
City Area Code	561
Local Phone Number	848‑4311
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		2,083,436

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets (Current Period Unaudited) - USD ($)	Nov. 30, 2024	Feb. 29, 2024
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.01	$ 0.01
CURRENT ASSETS
Cash and cash equivalents	$ 3,727,000	$ 2,217,000
Marketable securities	1,023,000	904,000
Accounts receivable	1,793,000	2,826,000
Inventories, net	3,998,000	4,132,000
Prepaid expenses and other current assets	333,000	532,000
TOTAL CURRENT ASSETS	10,874,000	10,611,000
Property, plant and equipment, net	8,724,000	7,356,000
Finance lease, right of use asset	0	1,715,000
Intangible assets	2,957,000	3,114,000
Deferred tax asset	1,590,000	1,837,000
Other assets	253,000	107,000
TOTAL ASSETS	24,398,000	24,740,000
CURRENT LIABILITIES
Accounts payable	391,000	439,000
Customer deposits	63,000	539,000
Accrued contingent consideration, current	542,000	465,000
Finance lease liability	0	1,750,000
Mortgage loans, current portion	151,000	111,000
Accrued expenses and other current liabilities	845,000	1,080,000
TOTAL CURRENT LIABILITIES	1,992,000	4,384,000
Accrued contingent consideration, non-current	663,000	751,000
Mortgage loans, net of current portion	3,803,000	2,537,000
TOTAL LIABILITIES	6,458,000	7,672,000
STOCKHOLDERS’ EQUITY
Preferred stock, $.01 par value, authorized 500,000 shares, none issued	0	0
Common stock, $.01 par value, authorized 10,000,000 shares, 2,083,436 shares outstanding, net of 487,827 treasury shares at November 30, 2024 and 2,083,436 shares outstanding, net of 487,827 treasury shares at February 29, 2024, respectively	21,000	21,000
Additional paid-in capital	1,834,000	1,834,000
Retained Earnings	17,497,000	16,625,000
Less treasury stock	(1,412,000)	(1,412,000)
TOTAL STOCKHOLDERS’ EQUITY	17,940,000	17,068,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 24,398,000	$ 24,740,000

Consolidated Condensed Balanc_2

Consolidated Condensed Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Nov. 30, 2024	Feb. 29, 2024
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.01	$ 0.01
Preferred Stock, Shares Authorized (in shares)	500,000	500,000
Preferred Stock, Shares Issued (in shares)	0	0
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.01	$ 0.01
Common Stock, Shares Authorized (in shares)	10,000,000	10,000,000
Common Stock, Shares, Outstanding (in shares)	2,083,436	2,083,436
Treasury Stock, Common, Shares (in shares)	487,827	487,827

Consolidated Condensed Statemen

Consolidated Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
Net sales	$ 3,369,000	$ 4,136,000	$ 10,917,000	$ 8,753,000
Cost of sales	2,368,000	3,059,000	7,503,000	6,172,000
Gross profit	1,001,000	1,077,000	3,414,000	2,581,000
Selling, general and administrative expenses	675,000	859,000	2,246,000	2,015,000
Operating income	326,000	218,000	1,168,000	566,000
Other income (loss)
Interest income	0	12,000	6,000	32,000
Interest expense	(67,000)	(55,000)	(194,000)	(108,000)
Dividend income	12,000	0	34,000	19,000
Realized gain on investments	13,000	0	46,000	332,000
Unrealized gain (loss) on investments	78,000	(108,000)	126,000	(745,000)
Other income	0	19,000	0	19,000
Total other (loss)	36,000	(132,000)	18,000	(451,000)
Net income (loss) before tax	362,000	86,000	1,186,000	115,000
Income taxes	(96,000)	0	(314,000)	0
Net income (loss)	$ 266,000	$ 86,000	$ 872,000	$ 115,000
Net income (loss) per common share - basic and diluted (in dollars per share)	$ 0.13	$ 0.04	$ 0.42	$ 0.06
Weighted average shares outstanding - basic and diluted (in shares)	2,083,436	2,083,436	2,083,436	2,083,436

Statements of Changes in Conden

Statements of Changes in Condensed Consolidated Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Treasury Stock, Common [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares)	2,571,263	(487,827)
Balance	$ 21	$ (1,412)	$ 1,834	$ 10,824	$ 11,267
Balance (in shares) at Feb. 28, 2023	2,571,263	(487,827)
Balance at Feb. 28, 2023	$ 21	$ (1,412)	1,834	10,824	11,267
Net (loss)	$ 0	$ 0	0	(171)	(171)
Balance (in shares) at May. 31, 2023	2,571,263	(487,827)
Balance at May. 31, 2023	$ 21	$ (1,412)	1,834	10,653	11,096
Net Income	$ 0	$ 0	0	(171)	(171)
Balance (in shares) at Feb. 28, 2023	2,571,263	(487,827)
Balance at Feb. 28, 2023	$ 21	$ (1,412)	1,834	10,824	11,267
Net (loss)					115
Balance (in shares) at Nov. 30, 2023	2,571,263	(487,827)
Balance at Nov. 30, 2023	$ 21	$ (1,412)	1,834	10,939	11,382
Net Income					115
Balance (in shares)	2,571,263	(487,827)
Balance	$ 21	$ (1,412)	1,834	10,653	11,096
Balance (in shares) at May. 31, 2023	2,571,263	(487,827)
Balance at May. 31, 2023	$ 21	$ (1,412)	1,834	10,653	11,096
Net (loss)	$ 0	$ 0	0	200	200
Balance (in shares) at Aug. 31, 2023	2,571,263	(487,827)
Balance at Aug. 31, 2023	$ 21	$ (1,412)	1,834	10,853	11,296
Net Income	$ 0	$ 0	0	200	200
Balance (in shares)	2,571,263	(487,827)
Balance	$ 21	$ (1,412)	1,834	10,853	11,296
Net (loss)	$ 0	$ 0	0	86	86
Balance (in shares) at Nov. 30, 2023	2,571,263	(487,827)
Balance at Nov. 30, 2023	$ 21	$ (1,412)	1,834	10,939	11,382
Net Income	$ 0	$ 0	0	86	86
Balance (in shares)	2,571,263	(487,827)
Balance	$ 21	$ (1,412)	1,834	10,939	11,382
Balance (in shares)	2,571,263	(487,827)
Balance	$ 21	$ (1,412)	1,834	16,625	17,068
Balance (in shares) at Feb. 29, 2024	2,571,263	(487,827)
Balance at Feb. 29, 2024	$ 21	$ (1,412)	1,834	16,625	17,068
Net (loss)	$ 0	$ 0	0	589	589
Balance (in shares) at May. 31, 2024	2,571,263	(487,827)
Balance at May. 31, 2024	$ 21	$ (1,412)	1,834	17,214	17,657
Net Income	$ 0	$ 0	0	589	589
Balance (in shares) at Feb. 29, 2024	2,571,263	(487,827)
Balance at Feb. 29, 2024	$ 21	$ (1,412)	1,834	16,625	17,068
Net (loss)					872
Balance (in shares) at Nov. 30, 2024	2,571,263	(487,827)
Balance at Nov. 30, 2024	$ 21	$ (1,412)	1,834	17,497	17,940
Net Income					872
Balance (in shares)	2,571,263	(487,827)
Balance	$ 21	$ (1,412)	1,834	17,214	17,657
Balance (in shares) at May. 31, 2024	2,571,263	(487,827)
Balance at May. 31, 2024	$ 21	$ (1,412)	1,834	17,214	17,657
Net (loss)	$ 0	$ 0	0	17	17
Balance (in shares) at Aug. 31, 2024	2,571,263	(487,827)
Balance at Aug. 31, 2024	$ 21	$ (1,412)	1,834	17,231	17,674
Net Income	$ 0	$ 0	0	17	17
Balance (in shares)	2,571,263	(487,827)
Balance	$ 21	$ (1,412)	1,834	17,231	17,674
Net (loss)	$ 0	$ 0	0	266	266
Balance (in shares) at Nov. 30, 2024	2,571,263	(487,827)
Balance at Nov. 30, 2024	$ 21	$ (1,412)	1,834	17,497	17,940
Net Income	$ 0	$ 0	0	266	266
Balance (in shares)	2,571,263	(487,827)
Balance	$ 21	$ (1,412)	$ 1,834	$ 17,497	$ 17,940

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023
Net income	$ 872	$ 115
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	420	393
Amortization of intangibles	157	14
Net realized and unrealized (losses) on investments	(174)	413
Accrued interest income on short-term investments	0	(16)
Accrued interest expense on contingent consideration	77	26
Change in net deferred taxes	248	0
Changes in Operating Assets and Liabilities:
Accounts receivable	1,033	(1,171)
Inventories	134	693
Prepaid expenses and other current assets	199	(5)
Other assets, non-current	(147)	42
Accounts payable	(48)	481
Customer deposits	(475)	260
Accrued expenses, other current and non-current liabilities	(236)	115
Net cash provided by operating activities	2,060	1,360
Investing activities
Proceeds from sale of marketable securities	647	882
Purchases of marketable securities	(592)	(70)
Maturities of short-term investments	0	1,000
Cash paid for acquisition, contingent consideration	(88)	(2,465)
Purchases of property and equipment	(1,788)	(162)
Net cash provided by (used in) investing activities	(1,821)	(815)
Financing activities
Payments on finance lease liabilities	(35)	(3)
Proceeds from mortgage loan	1,400	0
Principal payments on mortgage loan	(94)	(80)
Net cash provided by (used in) financing activities	1,271	(83)
Net increase in cash and cash equivalents	1,510	462
Cash and cash equivalents - beginning of the year	2,217	1,447
Cash and cash equivalents - end of period	3,727	1,909
Non-cash transactions
Financing right of use asset and liability extinguished	1,744	1,744
Supplemental disclosures of cash flow data
Income taxes paid	0	0
Interest expense paid	$ 94	$ 53

Note 1 - The Company and Operat

Note 1 - The Company and Operations	9 Months Ended
	Nov. 30, 2024
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	1. THE COMPANY AND OPERATIONS Solitron Devices, Inc., a Delaware corporation (the “Company” or “Solitron”), designs, develops, manufactures, and markets solid-state semiconductor components and related devices primarily for the military and aerospace markets. The Company was incorporated under the laws of the State of New York in 1959 August 1987. September 2023, 1980,

Note 2 - Summary of Significant

Note 2 - Summary of Significant Accounting Policies	9 Months Ended
	Nov. 30, 2024
Notes to Financial Statements
Significant Accounting Policies [Text Block]	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States for interim financial information and with the instructions to Form 10 8 X. not The unaudited financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods. The results of operations for the three nine November 30, 2024 not February 28, 2025 The information included in this Form 10 10 February 29, 2024 Use of Estimates The consolidated condensed financial statements are prepared in accordance with U.S. GAAP. Preparation of these consolidated condensed financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. The Company could have reasonably used different accounting estimates. This applies in particular to inventory and valuation allowance for deferred tax assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial statement presentation, financial condition, results of operations and cash flows will be affected. Cash and Cash Equivalents Cash and cash equivalents include demand deposits and money market accounts. The Company considers any short-term, highly liquid investments with maturities of three Investment in Marketable Securities Investment in Securities includes investments in equity securities. Investments in securities are reported at fair value with changes in unrecognized gains or losses included in other income on the condensed consolidated statements of operations. The following table summarizes the Company’s marketable securities: November 30, 2024 Gross Gross Unrealized Unrealized Marketable Securities: Cost Gains Losses Fair Value Common Stocks $ 574,000 $ 454,000 $ (5,000 ) $ 1,023,000 February 29, 2024 Gross Gross Unrealized Unrealized Marketable Securities: Cost Gains Losses Fair Value Common Stocks $ 581,000 $ 375,000 $ (52,000 ) $ 904,000 At November 30, 2024 February 29, 2024 $86,000 Fair Value of Financial Instruments Accounting Standards Codification (“ASC”) Topic 820, 820 three Level 1: Observable inputs that reflect unadjusted quoted prices for identical assets or liabilities traded in active markets. Level 2: Inputs other than quoted prices included within Level 1 Level 3: Inputs that are generally unobservable. These inputs may The table below shows the Company’s marketable securities as of November 30, 2024 February 29, 2024 November 30, 2024 Level 1 Level 2 Level 3 Total Common Stocks $ 1,023,000 $ - $ - $ 1,023,000 February 29, 2024 Level 1 Level 2 Level 3 Total Common Stocks $ 904,000 $ - $ - $ 904,000 The carrying amounts of the Company’s short-term financial instruments, including accounts receivable, accounts payable, accrued expenses and other liabilities approximate their fair value due to the relatively short period to maturity for these instruments. The carrying value of long-term debt approximates fair value since the related rates of interest approximate current market rates. Accounts Receivable Accounts receivable are stated at amounts management expects to collect from outstanding balances and do not not not November 30, 2024 February 29, 2024 The allowance estimate is derived from a review of the Company’s historical losses based on the aging of receivables. This estimate is adjusted for management’s assessment of current conditions, reasonable and supportable forecasts regarding future events, and any other factors deemed relevant by the Company. The Company believes historical loss information is a reasonable starting point in which to calculate the expected allowance for credit losses as the Company’s portfolio segment has remained consistent since the Company’s inception. The allowance for credit losses was $0 as of November 30, 2024 February 29, 2024 The Company writes off receivables when there is information that indicates the debtor is facing significant financial difficulty and there is no nine November 30, 2024 November 30, 2023 Shipping and Handling Shipping and handling costs billed to customers are recorded in net sales. Shipping costs incurred by the Company are recorded in cost of sales. Inventories Inventories are stated at the lower of cost and net realizable value. Cost is determined using the “first-in, first not two zero The Company does not not twelve The Company’s inventory valuation policy is as follows: Raw material /Work in process: All material acquired or processed in the last two three not two three five Finished goods: All finished goods with firm orders for later delivery are valued at the lower of cost or net realizable value. All finished goods with no Direct labor costs: Direct labor costs are allocated to finished goods and work in process inventory based on engineering estimates of the number of man-hours required from the different direct labor departments to bring each device to its particular level of completion. Property, Plant, Equipment, and Leasehold Improvements Property, plant, and equipment is recorded at cost. Major renewals and improvements are capitalized, while maintenance and repairs that do not Building (years) 39 Building Improvements (years) 15 Leasehold Improvements Shorter of 10 years or life of lease Machinery and Equipment (years) 5 Concentrations of Credit Risk Financial instruments, which potentially subject the Company to concentration of credit risk, consist principally of cash and account receivables. The Company places its cash with high credit quality institutions. At times, such amounts may not not November 30, 2024 $250,000. November 30, 2024 February 29, 2024 Net Income (Loss) Per Common Share Net income (loss) per common share is presented in accordance with ASC 260 10 not no three nine November 30, 2024 November 30, 2023 no Revenue Recognition The Company records revenue in accordance with ASC Topic 606, The core principle of the guidance in Topic 606 To achieve that core principle, the Company applied the following steps: 1. The Company designs, develops, manufactures and markets solid-state semiconductor components and related devices. The Company’s products are used as components primarily in the military and aerospace markets. The Company’s revenues are from purchase orders and/or contracts with customers associated with manufacture of products. We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. 2. The majority of the Company’s purchase orders or contracts with customers contain a single performance obligation, the shipment of products. 3. The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer at a fixed price per unit shipped based on the terms of the contract or purchase order with the customer. To the extent our actual costs vary from the fixed price that was negotiated, we will generate more or less profit or could incur a loss. 4. 5. This performance obligation is satisfied when control of the product is transferred to the customer, which generally occurs upon shipment. The Company receives purchase orders for products to be delivered over multiple dates that may In addition, the Company may We recognize revenue on sales to distributors when the distributor takes control of the products ("sold-to" model). We have agreements with distributors that allow distributors a limited credit for unsaleable products, which we refer to as a "scrap allowance." Consistent with industry practice, we also have a "stock, ship and debit" program whereby we consider requests by distributors for credits on previously purchased products that remain in distributors' inventory, to enable the distributors to offer more competitive pricing. We have contractual arrangements whereby we provide distributors with protection against price reductions initiated by us after product is sold by us to the distributor and prior to resale by the distributor. In addition, we have a termination clause in one 60 We recognize the estimated variable consideration to be received as revenue and record a related accrued expense for the consideration not Related Party Transactions The Company currently purchases and has purchased in the past die and wafers, as specified by the Company's customers, from ES Components. Mr. Aubrey, a director of the Company is a minority owner, and an immediate family member of the majority owner of ES Components. For the three nine November 30, 2024 three nine November 30, 2023 three nine November 30, 2024 November 30, 2023 Stock based Compensation The Company records stock-based compensation in accordance with the provisions of ASC Topic 718, 718, No three nine November 30, 2024 November 30, 2023

Note 3 - Revenue Recognition

Note 3 - Revenue Recognition	9 Months Ended
	Nov. 30, 2024
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	3. REVENUE RECOGNITION Sales returns and allowances accrual activity is shown below for the three nine November 30, 2024 November 30, 2023 Fiscal quarters ended Nine fiscal months ended November 30, 2024 November 30, 2023 November 30, 2024 November 30, 2023 Beginning Balance $ 363,000 $ 471,000 $ 471,000 $ 471,000 Accrued Allowances (33,000 ) - (141,000 ) - Credits Issued - - - - Ending Balance $ 330,000 $ 471,000 $ 330,000 $ 471,000 As mentioned in Note 2 one 60 November 30, 2024 February 29, 2024 The Company warrants that its products, when delivered, will be free from defects in material workmanship under normal use and service. The obligations are limited to replacing, repairing, or reimbursing for, at the option of the Company, any products that are returned within one not

Note 4 - Inventories

Note 4 - Inventories	9 Months Ended
	Nov. 30, 2024
Notes to Financial Statements
Inventory Disclosure [Text Block]	4. INVENTORIES As of November 30, 2024 Gross Reserve Net Raw Materials $ 2,589,000 $ (482,000 ) $ 2,107,000 Work-In-Process 5,160,000 (3,883,000 ) 1,277,000 Finished Goods 1,098,000 (484,000 ) 614,000 Totals $ 8,847,000 $ (4,849,000 ) $ 3,998,000 As of February 29, 2024 Gross Reserve Net Raw Materials $ 2,492,000 $ (441,000 ) $ 2,051,000 Work-In-Process 5,274,000 (3,894,000 ) 1,380,000 Finished Goods 1,150,000 (449,000 ) 701,000 Totals $ 8,916,000 $ (4,784,000 ) $ 4,132,000 Wafer bank inventory (completed wafers that are available to be consumed in the Company’s products), net of reserves, totaled $246,000 as of November 30, 2024 February 29, 2024 November 30, 2024 100% 2018 2022. not twelve not not

Note 5 - Accrued Expenses and O

Note 5 - Accrued Expenses and Other Current Liabilities	9 Months Ended
	Nov. 30, 2024
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	5. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES As of November 30, 2024 February 29, 2024 November 30, 2024 February 29, 2024 Payroll and related employee benefits $ 415,000 $ 449,000 Legal fees 27,000 21,000 Property, sales, and franchise taxes 73,000 25,000 Return allowance 330,000 471,000 Other liabilities - 114,000 Totals $ 845,000 $ 1,080,000

Note 6 - Disaggregation of Reve

Note 6 - Disaggregation of Revenue and Major Customers	9 Months Ended
	Nov. 30, 2024
Notes to Financial Statements
Disaggregation of Revenue and Major Customers [Text Block]	6. DISAGGREGATION OF REVENUE AND MAJOR CUSTOMERS Revenues from domestic and export sales are attributed to a global geographic region according to the location of the customer’s primary manufacturing or operating facilities. Revenues from domestic and export sales to unaffiliated customers for the three November 30, 2024 November 30, 2023 Geographic Region November 30, 2024 November 30, 2023 Europe and Australia $ 13,000 $ 1,000 Canada and Latin America - 1,000 Far East and Middle East - - United States 3,356,000 4,134,000 Totals $ 3,369,000 $ 4,136,000 For the three November 30, 2024 November 30, 2023 not Revenues from domestic and export sales to unaffiliated customers for the nine November 30, 2024 November 30, 2023 Geographic Region November 30, 2024 November 30, 2023 Europe and Australia $ 46,000 $ 4,000 Canada and Latin America - 2,000 Far East and Middle East - - United States 10,871,000 8,747,000 Totals $ 10,917,000 $ 8,753,000 For the nine November 30, 2024 November 30, 2023 not Customers who contributed ten three November 30, 2024 November 30, 2023 Customer November 30, 2024 Customer November 30, 2023 1. RTX (Raytheon) 41 % 1. ConMed Linvatec 29 % 2. ConMed Linvatec 31 % 2. RTX (Raytheon) 28 % 3. L3Harris 19 % Totals 72 % Totals 76 % Customers who contributed ten nine November 30, 2024 November 30, 2023 Customer November 30, 2024 Customer November 30, 2023 1. ConMed Linvatec 35 % 1. RTX (Raytheon) 39 % 2. RTX (Raytheon) 31 % 2. L3Harris 17 % 3. ConMed Linvatec 14 % Totals 66 % Totals 70 %

Note 7 - Major Suppliers

Note 7 - Major Suppliers	9 Months Ended
	Nov. 30, 2024
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	7. MAJOR SUPPLIERS For the three November 30, 2024 three No 10% For the nine November 30, 2024 two No 10% For the three November 30, 2023 two No 10% For the nine November 30, 2023 four No 10%

Note 8 - Commitments and Contin

Note 8 - Commitments and Contingencies	9 Months Ended
	Nov. 30, 2024
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	8. COMMITMENTS AND CONTINGENCIES Finance lease: In connection with the Acquisition of MEI, the Company also entered into a Lease Agreement pursuant to which it agreed to lease the facility occupied by MEI, consisting of approximately 10,926 square feet of useable office and production space in Orange County, Florida for $10,650 per month. The Lease Agreement had an initial term of three two five six May 21, 2024. 9 Under ASC 842 10 25 2 five one February 29, 2024 Fiscal Year Ending February 29 Amount 2024 1,750,000 Total Future Undiscounted Cash Flows $ 1,750,000 Less Imputed Interest to be recognized in lease expense - Finance Lease Liabilities, as reported $ 1,750,000 Balance Sheet Classification February 29, 2024 Assets Finance lease right-of-use assets, September 1, 2023 $ 1,744,000 Amortization for the six months ended February 29, 2024 (29,000 ) Total finance lease right-of-use asset, February 29, 2024 $ 1,715,000 Liabilities Current Finance lease liability, short-term $ 1,750,000 Non-current Finance lease liability, long-term - Total lease liabilities $ 1,750,000 Contingencies: We may November 30, 2024 no

Note 9 - Notes Payable

Note 9 - Notes Payable	9 Months Ended
	Nov. 30, 2024
Notes to Financial Statements
Debt Disclosure [Text Block]	9. NOTES PAYABLE On April 16, 2021, March 1, 2021. April 15, 2031. May 15, 2021, 1.15:1.0, twelve no On June 29, 2022, 2.1, 2.4, On May 21, 2024, 401 September 1, 2023, six May 21, 2024, 1 2 Pursuant to the loan documentation, the Bank has advanced $1,400,000 to the Company for the purchase of the Micro Property. The Company agreed to pay installments of principal and interest in the amount of $10,444 on the first July 1, 2024, May 1, 2034. May 31, 2034. may May 31, 2034. As of November 30, 2024 February 28/29: Total Principal Payments 2025 $ 38,000 2026 152,000 2027 159,000 2028 167,000 2029 174,000 thereafter 3,264,000 Total principal payments $ 3,954,000

Note 10 - Stockholders' Equity

Note 10 - Stockholders' Equity	9 Months Ended
	Nov. 30, 2024
Notes to Financial Statements
Equity [Text Block]	10. STOCKHOLDERS ’ EQUITY Repurchase Program On October 14, 2024, may The Company did not three nine November 30, 2024 November 30, 2023

Note 11 - Subsequent Events

Note 11 - Subsequent Events	9 Months Ended
	Nov. 30, 2024
Notes to Financial Statements
Subsequent Events [Text Block]	11. SUBSEQUENT EVENTS

Insider Trading Arrangements

Insider Trading Arrangements	9 Months Ended
	Nov. 30, 2024
Insider Trading Arr Line Items
Material Terms of Trading Arrangement [Text Block]	– OTHER INFORMATION
Non-Rule 10b5-1 Arrangement Adopted [Flag]	false
Rule 10b5-1 Arrangement Adopted [Flag]	false
Non-Rule 10b5-1 Arrangement Terminated [Flag]	false
Rule 10b5-1 Arrangement Terminated [Flag]	false

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Nov. 30, 2024
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States for interim financial information and with the instructions to Form 10 8 X. not The unaudited financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods. The results of operations for the three nine November 30, 2024 not February 28, 2025 The information included in this Form 10 10 February 29, 2024
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The consolidated condensed financial statements are prepared in accordance with U.S. GAAP. Preparation of these consolidated condensed financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. The Company could have reasonably used different accounting estimates. This applies in particular to inventory and valuation allowance for deferred tax assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial statement presentation, financial condition, results of operations and cash flows will be affected.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents Cash and cash equivalents include demand deposits and money market accounts. The Company considers any short-term, highly liquid investments with maturities of three
Investment, Policy [Policy Text Block]	Investment in Marketable Securities Investment in Securities includes investments in equity securities. Investments in securities are reported at fair value with changes in unrecognized gains or losses included in other income on the condensed consolidated statements of operations. The following table summarizes the Company’s marketable securities: November 30, 2024 Gross Gross Unrealized Unrealized Marketable Securities: Cost Gains Losses Fair Value Common Stocks $ 574,000 $ 454,000 $ (5,000 ) $ 1,023,000 February 29, 2024 Gross Gross Unrealized Unrealized Marketable Securities: Cost Gains Losses Fair Value Common Stocks $ 581,000 $ 375,000 $ (52,000 ) $ 904,000 At November 30, 2024 February 29, 2024 $86,000
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments Accounting Standards Codification (“ASC”) Topic 820, 820 three Level 1: Observable inputs that reflect unadjusted quoted prices for identical assets or liabilities traded in active markets. Level 2: Inputs other than quoted prices included within Level 1 Level 3: Inputs that are generally unobservable. These inputs may The table below shows the Company’s marketable securities as of November 30, 2024 February 29, 2024 November 30, 2024 Level 1 Level 2 Level 3 Total Common Stocks $ 1,023,000 $ - $ - $ 1,023,000 February 29, 2024 Level 1 Level 2 Level 3 Total Common Stocks $ 904,000 $ - $ - $ 904,000 The carrying amounts of the Company’s short-term financial instruments, including accounts receivable, accounts payable, accrued expenses and other liabilities approximate their fair value due to the relatively short period to maturity for these instruments. The carrying value of long-term debt approximates fair value since the related rates of interest approximate current market rates.
Receivable [Policy Text Block]	Accounts Receivable Accounts receivable are stated at amounts management expects to collect from outstanding balances and do not not not November 30, 2024 February 29, 2024 The allowance estimate is derived from a review of the Company’s historical losses based on the aging of receivables. This estimate is adjusted for management’s assessment of current conditions, reasonable and supportable forecasts regarding future events, and any other factors deemed relevant by the Company. The Company believes historical loss information is a reasonable starting point in which to calculate the expected allowance for credit losses as the Company’s portfolio segment has remained consistent since the Company’s inception. The allowance for credit losses was $0 as of November 30, 2024 February 29, 2024 The Company writes off receivables when there is information that indicates the debtor is facing significant financial difficulty and there is no nine November 30, 2024 November 30, 2023
Shipping And Handling Costs [Policy Text Block]	Shipping and Handling Shipping and handling costs billed to customers are recorded in net sales. Shipping costs incurred by the Company are recorded in cost of sales.
Inventory, Policy [Policy Text Block]	Inventories Inventories are stated at the lower of cost and net realizable value. Cost is determined using the “first-in, first not two zero The Company does not not twelve The Company’s inventory valuation policy is as follows: Raw material /Work in process: All material acquired or processed in the last two three not two three five Finished goods: All finished goods with firm orders for later delivery are valued at the lower of cost or net realizable value. All finished goods with no Direct labor costs: Direct labor costs are allocated to finished goods and work in process inventory based on engineering estimates of the number of man-hours required from the different direct labor departments to bring each device to its particular level of completion.
Property, Plant and Equipment, Policy [Policy Text Block]	Property, Plant, Equipment, and Leasehold Improvements Property, plant, and equipment is recorded at cost. Major renewals and improvements are capitalized, while maintenance and repairs that do not Building (years) 39 Building Improvements (years) 15 Leasehold Improvements Shorter of 10 years or life of lease Machinery and Equipment (years) 5
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk Financial instruments, which potentially subject the Company to concentration of credit risk, consist principally of cash and account receivables. The Company places its cash with high credit quality institutions. At times, such amounts may not not November 30, 2024 $250,000. November 30, 2024 February 29, 2024
Earnings Per Share, Policy [Policy Text Block]	Net Income (Loss) Per Common Share Net income (loss) per common share is presented in accordance with ASC 260 10 not no three nine November 30, 2024 November 30, 2023 no
Revenue from Contract with Customer [Policy Text Block]	Revenue Recognition The Company records revenue in accordance with ASC Topic 606, The core principle of the guidance in Topic 606 To achieve that core principle, the Company applied the following steps: 1. The Company designs, develops, manufactures and markets solid-state semiconductor components and related devices. The Company’s products are used as components primarily in the military and aerospace markets. The Company’s revenues are from purchase orders and/or contracts with customers associated with manufacture of products. We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. 2. The majority of the Company’s purchase orders or contracts with customers contain a single performance obligation, the shipment of products. 3. The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer at a fixed price per unit shipped based on the terms of the contract or purchase order with the customer. To the extent our actual costs vary from the fixed price that was negotiated, we will generate more or less profit or could incur a loss. 4. 5. This performance obligation is satisfied when control of the product is transferred to the customer, which generally occurs upon shipment. The Company receives purchase orders for products to be delivered over multiple dates that may In addition, the Company may We recognize revenue on sales to distributors when the distributor takes control of the products ("sold-to" model). We have agreements with distributors that allow distributors a limited credit for unsaleable products, which we refer to as a "scrap allowance." Consistent with industry practice, we also have a "stock, ship and debit" program whereby we consider requests by distributors for credits on previously purchased products that remain in distributors' inventory, to enable the distributors to offer more competitive pricing. We have contractual arrangements whereby we provide distributors with protection against price reductions initiated by us after product is sold by us to the distributor and prior to resale by the distributor. In addition, we have a termination clause in one 60 We recognize the estimated variable consideration to be received as revenue and record a related accrued expense for the consideration not
Related Party Transactions [Policy Text Block]	Related Party Transactions The Company currently purchases and has purchased in the past die and wafers, as specified by the Company's customers, from ES Components. Mr. Aubrey, a director of the Company is a minority owner, and an immediate family member of the majority owner of ES Components. For the three nine November 30, 2024 three nine November 30, 2023 three nine November 30, 2024 November 30, 2023
Share-Based Payment Arrangement [Policy Text Block]	Stock based Compensation The Company records stock-based compensation in accordance with the provisions of ASC Topic 718, 718, No three nine November 30, 2024 November 30, 2023

Note 2 - Summary of Significa_2

Note 2 - Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Nov. 30, 2024
Notes Tables
Marketable Securities [Table Text Block]	November 30, 2024 Gross Gross Unrealized Unrealized Marketable Securities: Cost Gains Losses Fair Value Common Stocks $ 574,000 $ 454,000 $ (5,000 ) $ 1,023,000 February 29, 2024 Gross Gross Unrealized Unrealized Marketable Securities: Cost Gains Losses Fair Value Common Stocks $ 581,000 $ 375,000 $ (52,000 ) $ 904,000
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	November 30, 2024 Level 1 Level 2 Level 3 Total Common Stocks $ 1,023,000 $ - $ - $ 1,023,000 February 29, 2024 Level 1 Level 2 Level 3 Total Common Stocks $ 904,000 $ - $ - $ 904,000
Property, Plant and Equipment [Table Text Block]	Building (years) 39 Building Improvements (years) 15 Leasehold Improvements Shorter of 10 years or life of lease Machinery and Equipment (years) 5

Note 3 - Revenue Recognition (T

Note 3 - Revenue Recognition (Tables)	9 Months Ended
	Nov. 30, 2024
Notes Tables
Sales Returns and Allowances Accrual Activity [Table Text Block]	Fiscal quarters ended Nine fiscal months ended November 30, 2024 November 30, 2023 November 30, 2024 November 30, 2023 Beginning Balance $ 363,000 $ 471,000 $ 471,000 $ 471,000 Accrued Allowances (33,000 ) - (141,000 ) - Credits Issued - - - - Ending Balance $ 330,000 $ 471,000 $ 330,000 $ 471,000

Note 4 - Inventories (Tables)

Note 4 - Inventories (Tables)	9 Months Ended
	Nov. 30, 2024
Notes Tables
Schedule of Inventory, Current [Table Text Block]	Gross Reserve Net Raw Materials $ 2,589,000 $ (482,000 ) $ 2,107,000 Work-In-Process 5,160,000 (3,883,000 ) 1,277,000 Finished Goods 1,098,000 (484,000 ) 614,000 Totals $ 8,847,000 $ (4,849,000 ) $ 3,998,000 Gross Reserve Net Raw Materials $ 2,492,000 $ (441,000 ) $ 2,051,000 Work-In-Process 5,274,000 (3,894,000 ) 1,380,000 Finished Goods 1,150,000 (449,000 ) 701,000 Totals $ 8,916,000 $ (4,784,000 ) $ 4,132,000

Note 5 - Accrued Expenses and_2

Note 5 - Accrued Expenses and Other Current Liabilities (Tables)	9 Months Ended
	Nov. 30, 2024
Notes Tables
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	November 30, 2024 February 29, 2024 Payroll and related employee benefits $ 415,000 $ 449,000 Legal fees 27,000 21,000 Property, sales, and franchise taxes 73,000 25,000 Return allowance 330,000 471,000 Other liabilities - 114,000 Totals $ 845,000 $ 1,080,000

Note 6 - Disaggregation of Re_2

Note 6 - Disaggregation of Revenue and Major Customers (Tables)	9 Months Ended
	Nov. 30, 2024
Notes Tables
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]	Geographic Region November 30, 2024 November 30, 2023 Europe and Australia $ 13,000 $ 1,000 Canada and Latin America - 1,000 Far East and Middle East - - United States 3,356,000 4,134,000 Totals $ 3,369,000 $ 4,136,000 Geographic Region November 30, 2024 November 30, 2023 Europe and Australia $ 46,000 $ 4,000 Canada and Latin America - 2,000 Far East and Middle East - - United States 10,871,000 8,747,000 Totals $ 10,917,000 $ 8,753,000
Disaggregation of Revenue [Table Text Block]	Customer November 30, 2024 Customer November 30, 2023 1. RTX (Raytheon) 41 % 1. ConMed Linvatec 29 % 2. ConMed Linvatec 31 % 2. RTX (Raytheon) 28 % 3. L3Harris 19 % Totals 72 % Totals 76 % Customer November 30, 2024 Customer November 30, 2023 1. ConMed Linvatec 35 % 1. RTX (Raytheon) 39 % 2. RTX (Raytheon) 31 % 2. L3Harris 17 % 3. ConMed Linvatec 14 % Totals 66 % Totals 70 %

Note 8 - Commitments and Cont_2

Note 8 - Commitments and Contingencies (Tables)	9 Months Ended
	Nov. 30, 2024
Notes Tables
Finance Lease, Liability, to be Paid, Maturity [Table Text Block]	February 29, 2024 Fiscal Year Ending February 29 Amount 2024 1,750,000 Total Future Undiscounted Cash Flows $ 1,750,000 Less Imputed Interest to be recognized in lease expense - Finance Lease Liabilities, as reported $ 1,750,000
Lessee, Finance Lease, Balance Sheet Classification [Table Text Block]	Balance Sheet Classification February 29, 2024 Assets Finance lease right-of-use assets, September 1, 2023 $ 1,744,000 Amortization for the six months ended February 29, 2024 (29,000 ) Total finance lease right-of-use asset, February 29, 2024 $ 1,715,000 Liabilities Current Finance lease liability, short-term $ 1,750,000 Non-current Finance lease liability, long-term - Total lease liabilities $ 1,750,000

Note 9 - Notes Payable (Tables)

Note 9 - Notes Payable (Tables)	9 Months Ended
	Nov. 30, 2024
Notes Tables
Schedule of Maturities of Long-Term Debt [Table Text Block]	Total Principal Payments 2025 $ 38,000 2026 152,000 2027 159,000 2028 167,000 2029 174,000 thereafter 3,264,000 Total principal payments $ 3,954,000

Note 2 - Summary of Significa_3

Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($) shares in Thousands	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023	Feb. 29, 2024
Deferred Tax Liabilities, Investments	$ 119,000		$ 119,000		$ 86,000
Accounts Receivable, after Allowance for Credit Loss, Current	1,793,000		1,793,000		2,826,000
Accounts Receivable, Allowance for Credit Loss	0		0		0
Accounts Receivable, Allowance for Credit Loss, Writeoff			0	$ 0
Cash, Uninsured Amount	$ 677,000		$ 677,000		$ 1,007,000
Common Stock Equivalents, Outstanding (in shares)	0	0	0	0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares (in shares)	0	0	0	0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)	0	0	0	0
ES Components [Member]
Revenues	$ 0	$ 0	$ 0	$ 0
Die from ES Components [Member]
Related Party Transaction, Purchases from Related Party	0	24,000	90,000	57,000
Used Equipment Purchased From ES Components [Member]
Related Party Transaction, Purchases from Related Party	$ 0	$ 0	$ 0	$ 0

Note 2 - Summary of Significa_4

Note 2 - Summary of Significant Accounting Policies - Schedule of Marketable Securities (Details) - USD ($)	Nov. 30, 2024	Feb. 29, 2024
Marketable securities, cost	$ 574,000	$ 581,000
Marketable securities, gross unrealized gains	454,000	375,000
Marketable securities, gross unrealized losses	(5,000)	(52,000)
Marketable securities, fair value	$ 1,023,000	$ 904,000

Note 2 - Summary of Significa_5

Note 2 - Summary of Significant Accounting Policies - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($)	Nov. 30, 2024	Feb. 29, 2024
Common Stocks, Marketable Securities	$ 1,023,000	$ 904,000
Fair Value, Inputs, Level 1 [Member]
Common Stocks, Marketable Securities	1,023,000	904,000
Fair Value, Inputs, Level 2 [Member]
Common Stocks, Marketable Securities	0	0
Fair Value, Inputs, Level 3 [Member]
Common Stocks, Marketable Securities	$ 0	$ 0

Note 2 - Summary of Significa_6

Note 2 - Summary of Significant Accounting Policies - Schedule of Property, Plant, and Equipment (Details)	Nov. 30, 2024
Building [Member]
Property, Plant and Equipment, Useful Life (Year)	39 years
Building Improvements [Member]
Property, Plant and Equipment, Useful Life (Year)	15 years
Leasehold Improvements [Member] | Maximum [Member]
Property, Plant and Equipment, Useful Life (Year)	10 years
Machinery and Equipment [Member]
Property, Plant and Equipment, Useful Life (Year)	5 years

Note 3 - Revenue Recognition (D

Note 3 - Revenue Recognition (Details Textual) - USD ($)	Nov. 30, 2024	Feb. 29, 2024
Inventory, Net	$ 3,998,000	$ 4,132,000
One Distributor [Member]
Inventory, Net	$ 1,281,000	$ 1,454,000

Note 3 - Revenue Recognition -

Note 3 - Revenue Recognition - Schedule of Sales Returns and Allowances Accrual Activity (Details) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
Beginning Balance	$ 363,000	$ 471,000	$ 471,000	$ 471,000
Accrued Allowances	(33,000)	0	(141,000)	0
Credits Issued	0	0	0	0
Ending Balance	$ 330,000	$ 471,000	$ 330,000	$ 471,000

Note 4 - Inventories (Details T

Note 4 - Inventories (Details Textual) - USD ($)	Nov. 30, 2024	Feb. 29, 2024
Inventory, Net	$ 3,998,000	$ 4,132,000
Wafer Bank Inventory [Member]
Inventory, Net	$ 246,000	$ 332,000

Note 4 - Inventories - Schedule

Note 4 - Inventories - Schedule of Inventory (Details) - USD ($)	Nov. 30, 2024	Feb. 29, 2024
Inventory, Gross	$ 8,847,000	$ 8,916,000
Inventory, Valuation Reserves	(4,849,000)	(4,784,000)
Inventory, Net	3,998,000	4,132,000
Raw Materials [Member]
Inventory, Gross	2,589,000	2,492,000
Inventory, Valuation Reserves	(482,000)	(441,000)
Inventory, Net	2,107,000	2,051,000
Work-in-process [Member]
Inventory, Gross	5,160,000	5,274,000
Inventory, Valuation Reserves	(3,883,000)	(3,894,000)
Inventory, Net	1,277,000	1,380,000
Finished Goods [Member]
Inventory, Gross	1,098,000	1,150,000
Inventory, Valuation Reserves	(484,000)	(449,000)
Inventory, Net	$ 614,000	$ 701,000

Note 5 - Accrued Expenses and_3

Note 5 - Accrued Expenses and Other Current Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)	Nov. 30, 2024	Feb. 29, 2024
Payroll and related employee benefits	$ 415,000	$ 449,000
Legal fees	27,000	21,000
Property, sales, and franchise taxes	73,000	25,000
Return allowance	330,000	471,000
Other liabilities	0	114,000
Totals	$ 845,000	$ 1,080,000

Note 6 - Disaggregation of Re_3

Note 6 - Disaggregation of Revenue and Major Customers (Details Textual) - Customer Concentration Risk [Member] - Revenue Benchmark [Member]	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
Customers with Government Contracts [Member]
Concentration Risk, Percentage	55%	64%	55%	78%
Non-military, Scientific, Industrial Customers and Distributors [Member]
Concentration Risk, Percentage	45%	36%	45%	22%

Note 6 - Disaggregation of Re_4

Note 6 - Disaggregation of Revenue and Major Customers - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details) - USD ($)	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
Revenues	$ 3,369,000	$ 4,136,000	$ 10,917,000	$ 8,753,000
Europe and Australia [Member]
Revenues	13,000	1,000	46,000	4,000
Canada and Latin America [Member]
Revenues	0	1,000	0	2,000
Far East and Middle East [Member]
Revenues	0	0	0	0
UNITED STATES
Revenues	$ 3,356,000	$ 4,134,000	$ 10,871,000	$ 8,747,000

Note 6 - Disaggregation of Re_5

Note 6 - Disaggregation of Revenue and Major Customers - Schedule of Revenue by Major Customers by Reporting Segments (Details) - Customer Concentration Risk [Member] - Revenue Benchmark [Member]	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
RTX (Raytheon) [Member]
Concentration Risk, Percentage	41%	28%	31%	39%
Customer Concentration Risk, Percentage	41%	28%	31%	39%
Conmed Linvatec [Member]
Concentration Risk, Percentage	31%	29%	35%	14%
Customer Concentration Risk, Percentage	31%	29%	35%	14%
L3Harris [Member]
Concentration Risk, Percentage		19%		17%
Customer Concentration Risk, Percentage		19%		17%
RTX (Raytheon) and ConMed Linvatec [Member]
Concentration Risk, Percentage	72%		66%
Customer Concentration Risk, Percentage	72%		66%
Conmed Linvatec, RTX (Raytheon), and L3Harris [Member]
Concentration Risk, Percentage		76%		70%
Customer Concentration Risk, Percentage		76%		70%

Note 7 - Major Suppliers (Detai

Note 7 - Major Suppliers (Details Textual) - Supplier Concentration Risk [Member] - Cost of Goods and Service Benchmark [Member]	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023
Concentration Risk, Number of Suppliers	3	2	2	4
Three Suppliers [Member]
Concentration Risk, Percentage	46%
Supplier, One [Member]
Concentration Risk, Percentage	22%	23%	42%	20%
Supplier, Two [Member]
Concentration Risk, Percentage	13%	22%	14%	17%
Supplier, Three [Member]
Concentration Risk, Percentage	11%			13%
Two Suppliers [Member]
Concentration Risk, Percentage		43%	56%
Four Suppliers [Member]
Concentration Risk, Percentage				60%
Supplier, Four [Member]
Concentration Risk, Percentage				10%

Note 8 - Commitments and Cont_3

Note 8 - Commitments and Contingencies (Details Textual)		3 Months Ended
	May 21, 2024 USD ($)	Nov. 30, 2024 USD ($) ft²	Feb. 29, 2024 USD ($)
Finance Lease, Liability, Current		$ 0	$ 1,750,000
Lessee, Finance Lease, Discount Rate		8%
Useable Office and Production Space in Orange County, Florida [Member]
Area of Real Estate Property (Square Foot) | ft²		10,926
Lessee, Finance Lease, Monthly Rent Amount		$ 10,650
Lessee, Finance Lease, Term of Contract (Year)		3 years
Lessee, Finance Lease, Renewal Term (Year)		5 years
Lessee, Finance Lease, Option to Purchase, Purchase Amount	$ 1,750,000	$ 1,750,000

Note 8 - Commitments and Cont_4

Note 8 - Commitments and Contingencies - Maturity of Lease (Details)	Feb. 29, 2024 USD ($)
2024	$ 1,750,000
Total Future Undiscounted Cash Flows	1,750,000
Less Imputed Interest to be recognized in lease expense	0
Finance Lease Liabilities, as reported	$ 1,750,000

Note 8 - Commitments and Cont_5

Note 8 - Commitments and Contingencies - Balance Sheet Classification (Details) - USD ($)	6 Months Ended
	Feb. 29, 2024	Nov. 30, 2024
Finance lease right-of-use assets, September 1, 2023	$ 1,744,000
Amortization for the six months ended February 29, 2024	(29,000)
Total finance lease right-of-use asset, February 29, 2024	1,715,000
Finance Lease, Liability, Current	1,750,000	$ 0
Finance lease liability, long-term	0
Finance Lease Liabilities, as reported	$ 1,750,000

Note 9 - Notes Payable (Details

Note 9 - Notes Payable (Details Textual) - USD ($)			3 Months Ended	12 Months Ended
	May 21, 2024	Apr. 16, 2021	Nov. 30, 2024	Aug. 31, 2024	Mar. 01, 2021
Useable Office and Production Space in Orange County, Florida [Member]
Lessee, Finance Lease, Option to Purchase, Purchase Amount	$ 1,750,000		$ 1,750,000
Notes Payable to Banks [Member]
Debt Instrument, Face Amount	$ 1,400,000				$ 2,940,000
Debt Instrument, Interest Rate, Stated Percentage	6.39%				3.80%
Debt Instrument, Periodic Payment	$ 10,444			$ 17,593
Debt Instrument, Contingency, Minimum Amount Required of Unrestricted, Unencumbered, Liquid Assets				$ 1,000,000
Proceeds from Issuance of Debt	1,400,000
Property in West Palm Beach, Florida [Member]
Asset Acquisition, Consideration Transferred		$ 4,200,000
Micro Property [Member]
Asset Acquisition, Consideration Transferred	$ 1,750,000

Note 9 - Notes Payable - Princi

Note 9 - Notes Payable - Principal Payments (Details) $ in Millions	Nov. 30, 2024 USD ($)
2025	$ 38
2026	152
2027	159
2028	167
2029	174
thereafter	3,264
Total principal payments	$ 3,954

Note 10 - Stockholders' Equity

Note 10 - Stockholders' Equity (Details Textual) - shares	3 Months Ended		9 Months Ended
	Nov. 30, 2024	Nov. 30, 2023	Nov. 30, 2024	Nov. 30, 2023	Oct. 14, 2024
Share Repurchase Program, Authorized, Number of Shares (in shares)					2,000,000
Treasury Stock, Shares, Acquired (in shares)	0	0	0	0